CPRT vs IMDX · P/E 19, rev $3.51B vs rev $271.0K
Copart Inc (CPRT) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. IMDX currently screens at market cap $0.
Not investment advice. Open the CPRT and IMDX stock pages for the full models.
Not investment advice.